Alliance Pharma PLC Major Interest in Shares (5907E)

TIDMAPH

RNS Number : 5907E

Alliance Pharma PLC

11 April 2014

 
 For immediate release   11 April 2014 
 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Major Interest in Shares

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was informed on 10 April 2014 that on 9 April 2014, Nigel Wray purchased 1,550,000 ordinary shares of 1p each in the Company.

Mr Wray's resultant holding is 39,656,995 ordinary shares, equivalent to 15.02% of the Company's issued share capital.

Mr Wray's Ordinary Shares are held as follows:

 
 Nominee                       Number of ordinary shares 
 
  Pershing Nominees Limited     14,992,407 
   Roy Nominees Limited          24,664,588 
                              -------------------------- 
 

For further information:

 
 Alliance Pharma plc                           + 44 (0) 1249 466966 
 John Dawson, Chief Executive 
 Richard Wright, Finance Director 
 
 Buchanan                                     + 44 (0) 20 7466 5000 
 Mark Court / Fiona Henson / Sophie Cowles 
 
 Numis Securities Limited                     + 44 (0) 20 7260 1000 
 Nominated Adviser: Michael Meade / Oliver 
  Cardigan 
 Corporate Broking: David Poutney 
 

Notes to editors:

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLSFSFMSFLSELL